• 1. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 2. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 3. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 4. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 5. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126

• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Aryl halides Aryl bromides

Research Brief on (4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)acetonitrile (CAS: 175137-59-4): Recent Advances and Applications

The compound (4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)acetonitrile (CAS: 175137-59-4) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in medicinal chemistry and drug discovery. This research brief aims to synthesize the latest findings related to this compound, highlighting its synthesis, biological activities, and potential therapeutic applications.

Recent studies have demonstrated that (4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)acetonitrile serves as a key intermediate in the synthesis of heterocyclic compounds, which are pivotal in the development of novel pharmaceuticals. Its structural features, including the bromo and cyano functional groups, make it a valuable building block for the construction of biologically active molecules. Researchers have successfully utilized this compound in the synthesis of pyrazole derivatives, which exhibit a wide range of pharmacological properties, including anti-inflammatory, antimicrobial, and anticancer activities.

One of the most notable advancements in the application of (4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)acetonitrile is its role in the development of kinase inhibitors. Kinases are critical targets in the treatment of various cancers and inflammatory diseases. Recent publications have highlighted the use of this compound in the design and synthesis of small-molecule inhibitors that selectively target specific kinase pathways, offering promising therapeutic potential. For instance, a 2023 study published in the Journal of Medicinal Chemistry reported the successful incorporation of this compound into a novel inhibitor series with potent activity against a range of cancer cell lines.

In addition to its applications in drug discovery, (4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)acetonitrile has also been explored in agrochemical research. Its derivatives have shown efficacy as fungicides and herbicides, contributing to the development of new crop protection agents. The compound's ability to act as a versatile synthon in organic synthesis further underscores its importance in both pharmaceutical and agricultural chemistry.

Despite these promising developments, challenges remain in optimizing the synthetic routes and scalability of (4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)acetonitrile. Recent efforts have focused on improving yield and purity through innovative catalytic methods and green chemistry approaches. For example, a 2024 study in Organic Process Research & Development demonstrated a more efficient and environmentally friendly synthesis of this compound using microwave-assisted techniques, reducing reaction times and waste generation.

In conclusion, (4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)acetonitrile (CAS: 175137-59-4) continues to be a compound of significant interest in chemical biology and pharmaceutical research. Its diverse applications, from drug discovery to agrochemical development, highlight its versatility and potential. Future research should focus on further elucidating its mechanistic roles and expanding its utility in the design of novel therapeutic agents. The ongoing advancements in synthetic methodologies and biological evaluations promise to unlock new opportunities for this compound in the years to come.

• 51108-53-3(1-Benzyl-4-bromo-3,5-dimethyl-1H-pyrazole)
• 1171717-09-1(4-Bromo-3,5-dimethyl-1-(3-methylbutyl)-1H-pyrazole)
• 925607-98-3(3-(4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)propan-1-ol)
• 13369-76-1(1-Allyl-4-bromo-3,5-dimethyl-1H-pyrazole)
• 1171526-62-7(4-Bromo-1-isobutyl-3,5-dimethyl-1H-pyrazole)
• 519018-28-1(4-Bromo-1-ethyl-3-methyl-1H-pyrazole)
• 51108-51-1(4-Bromo-1-ethyl-3,5-dimethyl-1H-pyrazole)
• 90006-21-6(3-(4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)propanenitrile)
• 1170132-58-7(N-2-(4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)ethyl-N,N-dimethylamine)
• 1134684-85-7(2-(3,5-Dimethyl-1H-pyrazol-1-yl)acetonitrile)